**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
|----------------|--------------------------------------|----------|-----------|
|----------------|--------------------------------------|----------|-----------|
| 52417-22-8 |9-Aminoacridine hydrochloride monohydr| >99 | unlisted |
+----------------+--------------------------------------+----------+-----------+
Text for R-phrases: see Section 16
Hazard Symbols: T
Risk Phrases: 25 40
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Toxic if swallowed. Limited evidence of a carcinogenic effect.The
toxicological properties of this material have not been fully
investigated.Possible risks of irreversible effects.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
May cause skin irritation.
Ingestion:
Harmful if swallowed. May cause irritation of the digestive tract.
The toxicological properties of this substance have not been fully
investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties
of this substance have not been fully investigated.
Chronic:
Possible risk of irreversible effects.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical
aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and
drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use agent most appropriate to extinguish fire. Use water spray, dry
chemical, carbon dioxide, or appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Clean up spills immediately, observing precautions in the Protective
Equipment section. Sweep up, then place into a suitable container for
disposal. Avoid generating dusty conditions. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Use with adequate ventilation.
Minimize dust generation and accumulation. Avoid contact with eyes,
skin, and clothing. Keep container tightly closed. Avoid ingestion
and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 134-50-9:
CAS# 52417-22-8:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant respirator use.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Powder
Color: yellow
Odor: None reported.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 300 deg C
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: 0.33g/100 ml water
Specific Gravity/Density: >1.0
Molecular Formula: C13H10N2.HCl.H2O
Molecular Weight: 248.71
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Dust generation, excess heat.
Incompatibilities with Other Materials:
Strong oxidizing agents, strong bases, acid anhydrides.
Hazardous Decomposition Products:
Hydrogen chloride, nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 134-50-9: AR7350000
CAS# 52417-22-8: AR6850000
LD50/LC50:
CAS# 134-50-9: Oral, mouse: LD50 = 78 mg/kg.
CAS# 52417-22-8.
Carcinogenicity:
9-Aminoacridine hydrochloride -
Not listed by ACGIH, IARC, or NTP.
9-Aminoacridine hydrochloride monohydrate -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.*
Hazard Class: 6.1
UN Number: 2811
Packing Group: III
IMO
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing Group: III
RID/ADR
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing group: III
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: T
Risk Phrases:
R 25 Toxic if swallowed.
R 40 Limited evidence of a carcinogenic effect.
Safety Phrases:
S 22 Do not breathe dust.
S 24/25 Avoid contact with skin and eyes.
S 28A After contact with skin, wash immediately with
plenty of water.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 134-50-9: No information available.
CAS# 52417-22-8: No information available.
Canada
CAS# 134-50-9 is listed on Canada's NDSL List.
CAS# 134-50-9 is not listed on Canada's Ingredient Disclosure List.
CAS# 52417-22-8 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 134-50-9 is listed on the TSCA inventory.
CAS# 52417-22-8 is not on the TSCA Inventory because it is a hydrate.
It is considered to be listed if the CAS number for the anhydrous form
is on the inventory (40CFR720.3(u)(2)).
**** SECTION 16 - ADDITIONAL INFORMATION ****
Text for R-phrases from Section 2
MSDS Creation Date: 9/02/1997 Revision #5 Date: 10/05/2004
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
(1-Bromovinyl)trimethylsilane
| 13683-41-5 |
|
Beta-Cyclodextrin
| 7585-39-9 |
|
Chromium(III) benzoylacetonate
| 16432-36-3 |
|
Trans-1-Decalone, 98%
| 21370-71-8 |
|
1-Phenylpiperazine hydrochloride, 97%
| 2210-93-7 |
|
2,6-Diformyl-4-Chlorophenol, 99%
| 32596-43-3 |
|
2,3-Diethyl-5-methylpyrazine, 99%
| 18138-04-0 |
|
(1R,2S)-(-)-Ephedrine, 98.5% (Dry Substance)
| 299-42-3 |
|
3,3'-Diethylthiadicarbocyanine Iodide, Laser Grade, 99% (UV-VIS)
| 514-73-8 |
|
Palladium-Poly(Ethylenimine), Silica Gel Supported Powder, 40-200
| 0-01-1 |
|
1,5-Pentanedithiol, 98%
| 928-98-3 |
|
4-Methyl-1-cyclohexene, 97%
| 591-47-9 |
|
Benzyltriethylammonium Bromide, 99%
| 5197-95-5 |
|
3-methylanisole, 99%
| 100-84-5 |
|
2,4,4-Trimethyl-1-pentene, 99%
| 107-39-1 |
|
N,N'-Bis(Methoxymethyl)Diaza-18-Crown-6 97%
| 0-01-1 |
|
Trimethylacetic anhydride, 99%
| 1538-75-6 |
|
Ethyl 3-endo-aminobicyclo [2,2,1] heptane-2-endo-carboxylate
| 95630-76-5 |
|
p-Ethyltoluene, 98%
| 622-96-8 |
|
Folinic Acid, Calcium Salt Pentahydrate, 85.0-110.0%, HPLC (on dried
| 1492-18-8 |
|
Mesityl oxide, 91% (gc)
| 141-79-7 |
|
Acetyl Methyl Carbinol (Pract), 93% (Titr.)
| 513-86-0 |
|
2-Carboxybenzaldehyde, 99%
| 119-67-5 |
|
Copper(i) iodide, 98%
| 7681-65-4 |
|
5-Vinyl-2-Norbornene, Tech.
| 3048-64-4 |
|
1-Hexadecene, tech., 92%, alpha-olefin c16
| 629-73-2 |
|
5-Amino-4,6-Dichloropyrimidine, 97%
| 5413-85-4 |
|
2-(2-Chlorophenyl)ethylamine, 98%
| 13078-80-3 |
|
Carbobenzoxyhydrazide, 98%
| 5331-43-1 |
|
Butyl acrylate, 99% (GC)
| 141-32-2 |
|
Diphenyl methyl phosphine, 98% (gc)
| 1486-28-8 |
|
Lithium Cyclohexanebutyrate
| 62638-00-0 |
|
3,4-Dichloroanisole, 99+%
| 36404-30-5 |
|
d-Valine, 98+%
| 640-68-6 |
|
2,5-Di-Tert-Butylhydroquinone, 99% (Titr.)
| 88-58-4 |
|
1-Iodohexane, 97% (gc)
| 638-45-9 |
|
4-Fluorobenzylamine, 97+%
| 140-75-0 |
|
Trimethylsilylisocyanate, 97%
| 1118-02-1 |
|
alpha-Ethylphenethyl alcohol, 97%
| 701-70-2 |
|
Chromotropic Acid Disodium Salt Dihydrate
| 5808-22-0 |
|
Silver(I) Fluoride, 99+%
| 7775-41-9 |
|
4-Fluorophenoxyacetic acid, 99+%
| 405-79-8 |
|
Propionaldehyde diethyl acetal, 97%
| 4744-08-5 |
|
1-Fluoro-2-iodobenzene, 99%
| 348-52-7 |
|
Methyl 4-Oxo-3-Piperidinecarboxylate Hydrochloride, 98% (TLC)
| 56026-52-9 |
|
10-Chloro-9-Anthraldehyde, 97%
| 10527-16-9 |
|
4-Bromo-2-Methylaniline, 97%
| 583-75-5 |
|
9-Aminoacridine hydrochloride monohydrate, 99+%
| 134-50-9 |
|
4,4'-bis(dimethylamino)benzhydrol, tech., 85% (dry subst.)
| 119-58-4 |
|
Methyl 4-hydroxyphenylacetate, 99%
| 14199-15-6 |
|
|